Post-therapy B Regulatory Cells Might early Predict Relapse in Hodgkin Lymphoma
Mediterr J Hematol Infect Dis
.
2022 May 1;14(1):e2022042.
doi: 10.4084/MJHID.2022.042.
eCollection 2022.
Authors
Valentina Giudice
1
2
,
Luca Pezzullo
2
,
Giuseppe Ciancia
3
,
Matteo D'Addona
2
,
Francesca D'Alto
2
,
Marisa Gorrese
2
,
Bianca Cuffa
2
,
Carmine Selleri
1
2
Affiliations
1
Department of Medicine, Surgery, and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy.
2
Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
3
Anatomy Patology, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
PMID:
35615322
PMCID:
PMC9083938
DOI:
10.4084/MJHID.2022.042
No abstract available
Keywords:
B regulatory cells; Hodgkin lymphoma; Immune system.